vs
Encompass Health Corp（EHC）与RXO, Inc.（RXO）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是RXO, Inc.的1.1倍（$1.5B vs $1.5B），Encompass Health Corp净利率更高（9.5% vs -3.1%，领先12.6%），Encompass Health Corp同比增速更快（9.9% vs -11.9%），Encompass Health Corp自由现金流更多（$116.7M vs $-9.0M），过去两年RXO, Inc.的营收复合增速更高（26.8% vs 8.3%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
RXO是总部位于美国的头部运输及物流解决方案供应商，核心业务覆盖货运经纪、大件商品最后一公里配送、运输管理服务与全链路供应链优化支持，主要服务北美制造业、零售业及电商领域的客户。
EHC vs RXO — 直观对比
营收规模更大
EHC
是对方的1.1倍
$1.5B
营收增速更快
EHC
高出21.8%
-11.9%
净利率更高
EHC
高出12.6%
-3.1%
自由现金流更多
EHC
多$125.7M
$-9.0M
两年增速更快
RXO
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.5B |
| 净利润 | $146.1M | $-46.0M |
| 毛利率 | — | — |
| 营业利润率 | 16.7% | -2.9% |
| 净利率 | 9.5% | -3.1% |
| 营收同比 | 9.9% | -11.9% |
| 净利润同比 | 20.8% | -84.0% |
| 每股收益（稀释后） | $1.43 | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCRXO
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.4B | $1.0B | ||
| Q2 24 | $1.3B | $930.0M | ||
| Q1 24 | $1.3B | $913.0M |
净利润EHCRXO
| Q4 25 | $146.1M | $-46.0M | ||
| Q3 25 | $126.5M | $-14.0M | ||
| Q2 25 | $142.1M | $-9.0M | ||
| Q1 25 | $151.5M | $-31.0M | ||
| Q4 24 | $120.9M | $-25.0M | ||
| Q3 24 | $108.2M | $-243.0M | ||
| Q2 24 | $114.1M | $-7.0M | ||
| Q1 24 | $112.5M | $-15.0M |
营业利润率EHCRXO
| Q4 25 | 16.7% | -2.9% | ||
| Q3 25 | 14.9% | -0.5% | ||
| Q2 25 | 16.2% | — | ||
| Q1 25 | 16.4% | -2.1% | ||
| Q4 24 | 14.3% | -1.4% | ||
| Q3 24 | 13.6% | -1.9% | ||
| Q2 24 | 14.3% | — | ||
| Q1 24 | 13.6% | -1.3% |
净利率EHCRXO
| Q4 25 | 9.5% | -3.1% | ||
| Q3 25 | 8.6% | -1.0% | ||
| Q2 25 | 9.7% | -0.6% | ||
| Q1 25 | 10.4% | -2.2% | ||
| Q4 24 | 8.6% | -1.5% | ||
| Q3 24 | 8.0% | -23.4% | ||
| Q2 24 | 8.8% | -0.8% | ||
| Q1 24 | 8.5% | -1.6% |
每股收益（稀释后）EHCRXO
| Q4 25 | $1.43 | $-0.28 | ||
| Q3 25 | $1.24 | $-0.08 | ||
| Q2 25 | $1.39 | $-0.05 | ||
| Q1 25 | $1.48 | $-0.18 | ||
| Q4 24 | $1.18 | $-0.17 | ||
| Q3 24 | $1.06 | $-1.81 | ||
| Q2 24 | $1.12 | $-0.06 | ||
| Q1 24 | $1.10 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $17.0M |
| 总债务越低越好 | $2.4B | $387.0M |
| 股东权益账面价值 | $2.4B | $1.5B |
| 总资产 | $7.1B | $3.3B |
| 负债/权益比越低杠杆越低 | 1.00× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资EHCRXO
| Q4 25 | $72.2M | $17.0M | ||
| Q3 25 | $48.7M | $25.0M | ||
| Q2 25 | $99.1M | $18.0M | ||
| Q1 25 | $95.8M | $16.0M | ||
| Q4 24 | $85.4M | $35.0M | ||
| Q3 24 | $147.8M | $55.0M | ||
| Q2 24 | $154.4M | $7.0M | ||
| Q1 24 | $134.4M | $7.0M |
总债务EHCRXO
| Q4 25 | $2.4B | $387.0M | ||
| Q3 25 | $2.4B | $387.0M | ||
| Q2 25 | $2.3B | $387.0M | ||
| Q1 25 | $2.3B | $387.0M | ||
| Q4 24 | $2.4B | $351.0M | ||
| Q3 24 | $2.3B | $352.0M | ||
| Q2 24 | $2.7B | $370.0M | ||
| Q1 24 | $2.7B | $351.0M |
股东权益EHCRXO
| Q4 25 | $2.4B | $1.5B | ||
| Q3 25 | $2.4B | $1.6B | ||
| Q2 25 | $2.3B | $1.6B | ||
| Q1 25 | $2.2B | $1.6B | ||
| Q4 24 | $2.1B | $1.6B | ||
| Q3 24 | $2.0B | $1.7B | ||
| Q2 24 | $1.8B | $579.0M | ||
| Q1 24 | $1.7B | $582.0M |
总资产EHCRXO
| Q4 25 | $7.1B | $3.3B | ||
| Q3 25 | $6.9B | $3.2B | ||
| Q2 25 | $6.8B | $3.2B | ||
| Q1 25 | $6.6B | $3.3B | ||
| Q4 24 | $6.5B | $3.4B | ||
| Q3 24 | $6.5B | $3.4B | ||
| Q2 24 | $6.4B | $1.8B | ||
| Q1 24 | $6.2B | $1.8B |
负债/权益比EHCRXO
| Q4 25 | 1.00× | 0.25× | ||
| Q3 25 | 1.01× | 0.24× | ||
| Q2 25 | 1.02× | 0.24× | ||
| Q1 25 | 1.08× | 0.24× | ||
| Q4 24 | 1.14× | 0.22× | ||
| Q3 24 | 1.20× | 0.21× | ||
| Q2 24 | 1.46× | 0.64× | ||
| Q1 24 | 1.54× | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $7.0M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $-9.0M |
| 自由现金流率自由现金流/营收 | 7.6% | -0.6% |
| 资本支出强度资本支出/营收 | 14.8% | 1.1% |
| 现金转化率经营现金流/净利润 | 2.37× | — |
| 过去12个月自由现金流最近4个季度 | $439.2M | $-8.0M |
8季度趋势，按日历期对齐
经营现金流EHCRXO
| Q4 25 | $346.0M | $7.0M | ||
| Q3 25 | $270.8M | $23.0M | ||
| Q2 25 | $270.2M | $23.0M | ||
| Q1 25 | $288.6M | $-2.0M | ||
| Q4 24 | $278.8M | $-7.0M | ||
| Q3 24 | $267.8M | $-7.0M | ||
| Q2 24 | $217.4M | $-5.0M | ||
| Q1 24 | $238.8M | $7.0M |
自由现金流EHCRXO
| Q4 25 | $116.7M | $-9.0M | ||
| Q3 25 | $83.7M | $9.0M | ||
| Q2 25 | $113.3M | $9.0M | ||
| Q1 25 | $125.5M | $-17.0M | ||
| Q4 24 | $80.1M | $-19.0M | ||
| Q3 24 | $120.3M | $-18.0M | ||
| Q2 24 | $60.5M | $-16.0M | ||
| Q1 24 | $99.4M | $-4.0M |
自由现金流率EHCRXO
| Q4 25 | 7.6% | -0.6% | ||
| Q3 25 | 5.7% | 0.6% | ||
| Q2 25 | 7.8% | 0.6% | ||
| Q1 25 | 8.6% | -1.2% | ||
| Q4 24 | 5.7% | -1.1% | ||
| Q3 24 | 8.9% | -1.7% | ||
| Q2 24 | 4.6% | -1.7% | ||
| Q1 24 | 7.6% | -0.4% |
资本支出强度EHCRXO
| Q4 25 | 14.8% | 1.1% | ||
| Q3 25 | 12.7% | 1.0% | ||
| Q2 25 | 10.8% | 1.0% | ||
| Q1 25 | 11.2% | 1.0% | ||
| Q4 24 | 14.1% | 0.7% | ||
| Q3 24 | 10.9% | 1.1% | ||
| Q2 24 | 12.1% | 1.2% | ||
| Q1 24 | 10.6% | 1.2% |
现金转化率EHCRXO
| Q4 25 | 2.37× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.90× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 2.31× | — | ||
| Q3 24 | 2.48× | — | ||
| Q2 24 | 1.91× | — | ||
| Q1 24 | 2.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
